Although histopathology examination was lacking, the consolidated evaluation of results from molecular cyto/genomic tests suggested that the entity of this particular case was DLBCL/HGBL-MYC/BCL2 according to the updated WHO classification [3], thus contributing to the proper classification of this lymphoma. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.